| 2025 | 2024 | ||
| Total | Total | ||
| Note | £’000 | £’000 | |
| Continuing operations | |||
Revenue | 2 | ||
Cost of sales | ( | ( | |
Gross profit | |||
Distribution costs | ( | ( | |
Administrative costs | ( | ( | |
Profit on disposal of subsidiary | 12.1 | ||
Operating profit/(loss) | 3 | ( | |
Finance income | 8 | ||
Finance costs | 8 | ( | ( |
Loss before taxation | ( | ( | |
Income tax credit | 9 | ||
Loss for the financial year from continuing operations | ( | ( | |
| Discontinued operations | |||
Profit/(loss) for the financial year from discontinued operations, net of tax | 12.2 | ( | |
Profit/(loss) for the financial year | ( |
| Other comprehensive income/(expense) | |||
| Items that may be subsequently reclassified to profit or loss: | |||
Exchange differences on translating foreign operations, net of tax | ( | ||
Net loss in cash flow hedges | ( | ( | |
Total comprehensive income/(expense) for the financial year | ( | ||
Basic and diluted loss per share continuing operations (£) | 26 | ( | ( |
Basic and diluted profit/(loss) per share discontinued operations (£) | 26 | ( | |
Basic and diluted profit/(loss) per share (£) | ( | ||
| Adjusted EBITDA | 2025 | 2024 2 | |
| Note | £’000 | £’000 | |
Operating profit/(loss) | ( | ||
| Adjustments for: | |||
Amortisation | 10 | ||
Amortisation of acquired intangibles | 10 | ||
Depreciation | 3 | ||
Adjusted items – cash | 4 | ||
Adjusted items – non-cash | 4 | ||
Adjusted items – non-cash impairment | 4 | ||
Share-based payments | 7 | ||
Profit on disposal of a subsidiary | ( | ||
Adjusted EBITDA 1 |
| 31 December | 31 December | ||
| 2025 | 2024 | ||
| Note | £’000 | £’000 | |
| Non-current assets | |||
Intangible assets | 10 | ||
Property, plant and equipment | 11 | ||
Right-of-use assets | 22 | ||
Other financial assets | 14 | ||
Deferred tax asset | 21 | ||
| Current assets | |||
Assets held for distribution | 12.2 | ||
Inventories | 13 | ||
Trade and other receivables | 15 | ||
Other financial assets | 14 | ||
Current tax asset | |||
Cash and cash equivalents | 16 | ||
Total assets | |||
| Equity | |||
Ordinary Shares | 23 | ||
Share premium | |||
Merger reserve | |||
Capital redemption reserve | |||
Hedging reserve | ( | ( | |
Cost of hedging reserve | |||
FX reserve | |||
Retained earnings | ( | ( | |
| Non-current liabilities | |||
Borrowings | 18 | ||
Other financial liabilities | 14 | ||
Lease liabilities | 22 | ||
Provisions | 19 | ||
Deferred tax liability | 21 | ||
| Current liabilities | |||
Liabilities held for distribution | 12.2 | ||
Contract liability | 20 | ||
Trade and other payables | 17 | ||
Borrowings | 18 | ||
Current tax liability | |||
Lease liabilities | 22 | ||
Provisions | 19 | ||
Other financial liabilities | 14 | ||
Dividend liability | 12.2 | ||
Total liabilities | |||
Total equity and liabilities |
| Capital | Cost of | |||||||||
| Ordinary | Share | Merger | redemption | FX | Hedging | hedging | Retained | Total | ||
| Shares | premium | reserve | reserve | reserve | reserve | reserve | earnings | equity | ||
| Note | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Balance at 1 January 2024 | ( | ( | ||||||||
Loss for the year | ( | ( | ||||||||
| Other comprehensive expense: | ||||||||||
Impact of foreign exchange | ||||||||||
| Movement on hedging | ||||||||||
instruments | ( | ( | ||||||||
| Total comprehensive | ||||||||||
(expense)/income for the year | ( | ( | ( | |||||||
Issue of Ordinary Share capital | ||||||||||
Share-based payments | 7 | |||||||||
Deferred tax in equity | 21 | ( | ( | |||||||
Dividend in specie | 12.2 | ( | ( | |||||||
Balance at 31 December 2024 | ( | ( | ||||||||
Balance at | ( | ( | ||||||||
Profit for the year | ||||||||||
| Other comprehensive loss: | ||||||||||
Impact of foreign exchange | ( | ( | ||||||||
| Movement on hedging | ||||||||||
instruments | ( | ( | ||||||||
| Total comprehensive | ||||||||||
(expense)/income for the year | ( | ( | ||||||||
Issue of Ordinary Share capital | ||||||||||
Convertible loan | ||||||||||
Share-based payments | 7 | |||||||||
Reserves movement of demerged entities | ( | ( | ||||||||
Balance at | ( | ( |
| 2025 | 2024 | ||
| Notes | £’000 | £’000 | |
| Cash flows from operating activities before adjusted cash flows | |||
Cash generated from operations | 25 | ||
Income tax paid | ( | ( | |
Net cash generated from operating activities before adjusted cash flows | |||
Cash flows relating to adjusted items | ( | ( | |
Net cash generated from operating activities | |||
| Cash flows from investing activities | |||
Acquisition of subsidiaries net of cash acquired | ( | ||
Proceeds from disposal of subsidiaries (net of cash disposed) | |||
Payments on distribution | 27 | ( | |
Purchase of property, plant and equipment | ( | ( | |
Purchase of intangible assets | ( | ( | |
Interest received | 8 | ||
Net cash from/(used) in investing activities | ( | ||
| Cash flows from financing activities | |||
Proceeds from issuance of Ordinary Shares net of fees | |||
Proceeds from the issue of convertible loan | |||
Interest paid | ( | ( | |
Repayment of lease liabilities | 22 | ( | ( |
Repayment of bank borrowings and loan fees | ( | ( | |
Proceeds from bank borrowings | |||
Net cash flow from financing activities | ( | ( | |
Net decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at the beginning of the year | |||
| Cash and cash equivalents at the end of the year | |||
(including cash held in disposal groups) | 16 | ||
| Cash and cash equivalents held in disposal group presented | |||
as held for distribution at the end of the year | |||
Cash and cash equivalents at the end of the year |
Segment | Activities |
THG Beauty | A digital-first brand owner, retailer and manufacturer in the prestige beauty market, with a portfolio of own brands across |
| skincare, haircare and cosmetics. Through its retail websites, including Lookfantastic, Dermstore and Cult Beauty, it is a | |
| route to market globally for third-party premium brands. | |
THG Nutrition | A group of digital-first nutrition brands, which includes the world’s largest online sports nutrition brand Myprotein and |
| its family of brands (Myvegan, Myvitamins, MP Activewear and MyPRO), with a vertically integrated business model | |
| supported by global THG production facilities. |
| FY 2025 | |||||||
| Total | Amortisation | Continuing | |||||
| reportable | Adjusted | and | operations | ||||
| THG Beauty | THG Nutrition | Central PLC | segments | items | depreciation | Statutory | |
| 2025 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Revenue | 1,107,864 | 609,130 | — | 1,716,994 | 883 | — | 1,717,877 |
Gross profit | 435,553 | 263,349 | — | 698,902 | (10,091) | (813) | 687,998 |
Margin % | 39.3% | 43.2% | — | 40.7% | — | — | 40.0% |
Adjusted EBITDA | 65,790 | 28,755 | (17,953) | 76,592 | — | — | 76,592 |
Margin % | 5.9% | 4.7% | — | 4.5% | — | — | 4.5% |
Depreciation | — | — | — | — | — | — | (32,459) |
Amortisation | — | — | — | — | — | — | (58,406) |
Share-based payments | — | — | — | — | — | — | (7,903) |
Profit on sale of a subsidiary | — | — | — | — | — | — | 60,537 |
Adjusted items | — | — | — | — | — | — | (30,227) |
Operating profit | — | — | — | — | — | — | 8,134 |
Finance income | — | — | — | — | — | — | 2,535 |
Finance costs | — | — | — | — | — | — | (80,052) |
Loss before taxation | — | — | — | — | — | — | (69,383) |
| FY 2024 | |||||||
| Total | Amortisation | Continuing | |||||
| reportable | Adjusted | and | operations | ||||
| THG Beauty | THG Nutrition | Central PLC | segments | items | depreciation | Statutory | |
| 20241 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Revenue 1,171,141 | 580,263 | — | 1,751,404 | — | — | 1,751,404 | |
Gross profit | 468,898 | 258,575 | — | 727,473 | (33,562) | (316) | 693,595 |
Margin % | 40.0% | 44.6% | — | 41.5% | — | — | 39.6% |
Adjusted EBITDA | 71,166 | 34,418 | (22,237) | 83,347 | — | — | 83,347 |
Margin % | 6.1% | 5.9% | — | 4.8% | — | — | 4.8% |
Depreciation | — | — | — | — | — | — | (24,824) |
Amortisation | — | — | — | — | — | — | (65,386) |
Share-based payments | — | — | — | — | — | — | (16,579) |
Adjusted items | — | — | — | — | — | — | (124,453) |
Operating loss | — | — | — | — | — | — | (147,895) |
Finance income | — | — | — | — | — | — | 9,049 |
Finance costs | — | — | — | — | — | — | (63,554) |
Loss before taxation | — | — | — | — | — | — | (202,400) |
| 2025 | 2024 | |
| £’000 | £’000 | |
UK | 909,755 | 820,517 |
USA | 296,957 | 362,874 |
Europe | 351,037 | 362,489 |
Rest of the world | 160,128 | 205,524 |
1,717,877 | 1,751,404 |
| 2025 | 2024 | |
| £’000 | £’000 | |
UK | 582,998 | 624,541 |
Europe | 45,353 | 42,270 |
Rest of the world | 380,307 | 385,728 |
1,008,658 | 1,052,539 |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
| Operating profit/(loss) has been arrived at after charging/(crediting): | |||
Adjusted items – cash | 4 | 14,299 | 24,547 |
Adjusted items – non-cash | 4 | 6,400 | 42,440 |
Adjusted items – non-cash impairment | 4 | 9,528 | 57,466 |
Employee costs | 136,338 | 142,253 | |
Share-based payments | 7 | 7,903 | 16,579 |
Depreciation on fixed assets | 11 | 12,012 | 13,092 |
Depreciation on right-of-use assets | 22 | 20,447 | 11,732 |
Amortisation | 10 | 16,520 | 19,880 |
Amortisation of acquired intangibles | 10 | 41,886 | 45,506 |
Net foreign exchange gain | (35) | (37) |
| 2025 | 2024 | |
| £’000 | £’000 | |
| Within revenue | ||
Other legal and professional revenue | 296 | — |
Revenue generated by loss-making brands and emerging territories arising from the strategic review | (1,179) | — |
(883) | — | |
| Within cost of sales | ||
Loss on disposal arising from the exit of discontinued or loss-making categories | 1,166 | 24,742 |
Inventory provision following strategic review and commercial rebrand | 2,976 | 8,820 |
Costs following the outcome of the strategic review of loss-making brands and emerging territories | 6,832 | — |
10,974 | 33,562 | |
| Within distribution costs | ||
Transportation, delivery and fulfilment costs | 721 | 1,268 |
721 | 1,268 | |
| Within administrative costs | ||
Impairment of assets – THG Experience | 589 | 14,854 |
Impairment of assets – discontinued categories | 8,939 | 57,466 |
Loss on property portfolio restructure | 963 | 528 |
Loss on disposal arising from the exit of discontinued or loss-making categories | — | 259 |
Costs following the outcome of the strategic review of loss-making brands and emerging territories | 1,193 | 172 |
Restructuring costs | 3,228 | 5,582 |
Acquisitions – restructuring and integration | 148 | 3,047 |
Onerous contracts | — | 7,075 |
Other legal and professional costs | 4,355 | 640 |
19,415 | 89,623 | |
Total adjusted items before tax | 30,227 | 124,453 |
Tax impact | (7,573) | (5,095) |
Total adjusted items | 22,654 | 119,358 |
Cash adjusting items before tax 1 | 14,299 | 24,547 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Fees in respect of the audit of the consolidated and parent company financial statements | 1,617 | 2,300 |
Total audit fees | 1,617 | 2,300 |
| Other services: | ||
– other assurance services 1 | 100 | 280 |
Total non-audit services | 100 | 280 |
Total fees | 1,717 | 2,580 |
| 2025 | 2024 | ||
| Note | £’000 | £’000 | |
Wages and salaries | 121,303 | 273,925 | |
Social security costs | 15,226 | 31,854 | |
Pension costs | 5,809 | 12,621 | |
Share-based payments | 7 | 7,903 | 16,579 |
Total | 150,241 | 334,979 | |
Continuing operations | 150,241 | 160,965 | |
Discontinued operations | — | 174,014 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Wages and salaries | 1,531 | 2,610 |
Social security costs | 217 | 248 |
Pension costs | 1 | 2 |
Total | 1,749 | 2,860 |
Continuing operations | 1,749 | 2,348 |
Discontinued operations | — | 512 |
| 2025 | 2024 | |
| Number | Number | |
Retail | 729 | 1,593 |
Administration | 838 | 1,655 |
Distribution | 1,299 | 3,056 |
Information technology | 46 | 823 |
Total | 2,912 | 7,127 |
Continuing operations | 2,912 | 3,140 |
Discontinued operations | — | 3,987 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Expense arising from equity-settled share-based payment transactions | 7,903 | 16,579 |
| 2025 | 2024 | |||
| Weighted | Weighted | |||
| 2025 | average | 2024 | average | |
| Number | exercise | Number of | exercise | |
| of shares | price | shares | price | |
As at 1 January | 88,454,894 | £0.04 | 68,718,060 | £0.04 |
Granted during the year | 9,585,327 | £0.00 | 33,574,120 | £0.02 |
Forfeited during the year | (6,362,060) | £0.04 | (3,854,758) | £0.00 |
Exercised during the year | (21,647,590) | £0.02 | (9,982,528) | £0.00 |
As at 31 December | 70,030,571 | £0.04 | 88,454,894 | £0.04 |
Exercisable as at 31 December | 56,797,472 | £0.05 | 6,072,570 | £0.00 |
| 2025 | 2024 | |
| £’000 | £’000 | |
| Finance income | ||
Bank interest receivable | 2,535 | 9,049 |
| Finance costs | ||
Bank interest payable and charges | 73,045 | 61,968 |
Interest on lease liabilities 1 | 7,0 07 | 1,586 |
80,052 | 63,554 |
| 2025 | 2024 | ||
| Note | £’000 | £’000 | |
| Current tax | |||
Tax charge for the year | 2,006 | 2,659 | |
Adjustments in respect of prior year | 929 | 1,230 | |
2,935 | 3,889 | ||
| Deferred tax | |||
Origination and reversal of temporary differences | (6,751) | (22,022) | |
Adjustments in respect of prior year | (1,892) | (3,734) | |
21 | (8,643) | (25,756) | |
Total income tax credit | (5,708) | (21,867) |
| 2025 | 2024 | |
| £’000 | £’000 | |
Loss before taxation from continuing operations | (69,383) | (202,400) |
Profit/(loss) before taxation from discontinued operations | 117,800 | (120,840) |
Profit/(loss) before taxation | 48,417 | (323,240) |
Tax at statutory rate of 25.0% (2024: 25.0%) | 12,104 | (80,810) |
| Tax effects of: | ||
Adjustments in respect of prior year | (963) | (353) |
Expenses not deductible | 625 | 17,011 |
Disposal/demerger of subsidiary entities | (44,986) | — |
Recognised previously unrecognised deferred tax asset | — | (3,700) |
Effect of tax rates in other jurisdictions | (326) | 650 |
Write down of previously recognised deferred tax asset | — | 26,429 |
Amounts not recognised | 29,198 | 40,251 |
Change in recognition of share scheme attributes | (1,360) | 3,422 |
Total income tax (credit)/expense | (5,708) | 2,900 |
Total income tax (credit) – continuing operations | (5,708) | (21,867) |
Total income tax expense – discontinued operations | — | 24,767 |
| Platform | ||||||
| development | Intellectual | New product | ||||
| Goodwill | costs | property | Brands | development | Total | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
| Cost or valuation | ||||||
At 1 January 2024 | 773,219 | 297,599 | 211,341 | 627,289 | 15,217 | 1,924,665 |
Transfers | — | (1,278) | 137 | — | 528 | (613) |
Additions | — | 50,046 | 14,474 | 591 | 3,043 | 68,154 |
Currency translation | 1,266 | 19 | 1,663 | 1,941 | (12) | 4,877 |
Disposals | (439) | (18,285) | (21,119) | (1,499) | (15) | (41,357) |
Transfers to assets held for distribution | (86,896) | (324,782) | (33,343) | (14,913) | (4,893) | (464,827) |
At 31 December 2024 | 687,150 | 3,319 | 173,153 | 613,409 | 13,868 | 1,490,899 |
Transfers | — | 5,401 | — | — | (5,401) | — |
Additions | — | 244 | 10,488 | — | 6,392 | 17,124 |
Currency translation | (20,107) | (206) | (9,785) | (19,304) | (14) | (49,416) |
Disposals | (30,197) | (248) | (21,465) | (478) | — | (52,388) |
At 31 December 2025 | 636,846 | 8,510 | 152,391 | 593,627 | 14,845 | 1,406,219 |
| Accumulated amortisation | ||||||
At 1 January 2024 | 302,981 | 17 7,102 | 93,200 | 137,661 | 6,338 | 717,282 |
Amortisation | — | 43,725 | 29,555 | 36,661 | 2,558 | 112,499 |
Currency translation | 392 | (4) | 1,086 | 370 | (14) | 1,830 |
Reclassification | — | — | 15,468 | (15,468) | — | — |
Disposals | (428) | (17,684) | (19,762) | (2,099) | (15) | (39,988) |
Impairment loss (net) | 40,521 | — | — | 15,770 | — | 56,291 |
Transfers to assets held for distribution | (85,483) | (199,925) | (24,620) | (3,235) | (2,074) | (315,337) |
At 31 December 2024 | 257,983 | 3,214 | 94,927 | 169,660 | 6,793 | 532,577 |
Amortisation | — | 2,319 | 21,581 | 34,174 | 332 | 58,406 |
Currency translation | (2,197) | (301) | (6,624) | (3,913) | 1 | (13,034) |
Disposals | — | (73) | (16,517) | (113) | — | (16,703) |
Impairment loss | — | — | — | 8,939 | — | 8,939 |
At 31 December 2025 | 255,786 | 5,159 | 93,367 | 208,747 | 7,126 | 570,185 |
| Net book value | ||||||
At 1 January 2024 | 470,238 | 120,497 | 118,141 | 489,628 | 8,879 | 1,207,383 |
At 31 December 2024 | 429,167 | 105 | 78,226 | 443,749 | 7,075 | 958,322 |
At 31 December 2025 | 381,060 | 3,351 | 59,024 | 384,880 | 7,719 | 836,034 |
| Key assumption | |
Discount rate | The post-tax discount rate used is 9.3% (pre-tax rate 10.0%). |
Forecast cash flows | Forecasts are based on assumptions from the Board-approved budget with projections covering a five-year period. |
| The key assumptions within the cash flow forecasts are the future revenue growth and EBITDA margin. The projections | |
| are based on the best estimate of future cash flows, taking into account externally available expectations that the beauty | |
| and online markets will continue to grow at a medium single-digit rate. During the year, THG Beauty has performed in line | |
| with the normalised expected range for both sales and EBITDA and therefore, coupled with the shift in strategy and the | |
| medium-term growth outlook for the prestige beauty market, the Directors believe the forecasts are both reasonable | |
| and consistent. | |
| Long-term | A long-term growth rate of 3.0% was used for cash flows after the five-year period which is based on long-term growth |
| growth rate | rate across the beauty market. |
| Key assumptions | |
Discount rate | The post tax discount rate used is 8.9% (pre-tax rate 9.6%). |
Forecast cash flows | Forecasts are based on assumptions from the Board-approved budget with projections covering a five-year period. The |
| key assumptions within the forecasts are the future revenue growth and EBITDA margin and are in line with market-wide | |
| forecast growth projections. | |
| Long term | A long-term growth rate of 3.0% was used for cash flows after the five-year period which is based on the long-term |
| growth rate | growth rate across sports and nutrition retailing. |
| Leasehold | ||||||
| Computer | improvements | |||||
| Motor | Plant and | Fixtures | equipment | and freehold | ||
| vehicles | machinery | and fittings | and software | buildings | Total | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
| Cost | ||||||
At 1 January 2024 | 2,263 | 152,963 | 106,865 | 133,150 | 109,607 | 504,848 |
Additions | 137 | 11,935 | 8,712 | 7,053 | 2,474 | 30,311 |
Transfers | 39 | 1,878 | (3,698) | 2,289 | 1,041 | 1,549 |
Currency translation differences | — | (332) | (783) | 142 | (33) | (1,006) |
Disposals | (116) | (2,349) | (1,345) | (780) | (874) | (5,464) |
Transfer to assets held for distribution | (1,893) | (109,492) | (83,062) | (124,692) | (42,431) | (361,570) |
At 31 December 2024 | 430 | 54,603 | 26,689 | 17,162 | 69,784 | 168,668 |
Additions | — | 2,579 | 854 | 190 | 613 | 4,236 |
Transfers | — | 3 | (123) | 2 | 118 | — |
Currency translation differences | 1 | (215) | 318 | (83) | (163) | (142) |
Disposals | (107) | (1,072) | (129) | (102) | (2,026) | (3,436) |
At 31 December 2025 | 324 | 55,898 | 27,609 | 17,169 | 68,326 | 169,326 |
| Accumulated depreciation | ||||||
At 1 January 2024 | 1,757 | 56,370 | 51,056 | 75,468 | 47,026 | 231,677 |
Depreciation (note 3) | 178 | 17,857 | 13,984 | 18,134 | 4,155 | 54,308 |
Transfers | — | 8 | (8) | — | — | — |
Impairment loss | — | 7,328 | — | — | 155 | 7,483 |
Currency translation differences | — | (92) | (224) | 100 | (50) | (266) |
Disposals | — | (2,347) | (1,212) | (780) | (494) | (4,833) |
Transfer to assets held for distribution | (1,773) | (47,492) | (42,213) | (83,675) | (9,438) | (184,591) |
At 31 December 2024 | 162 | 31,632 | 21,383 | 9,247 | 41,354 | 103,778 |
Depreciation (note 3) | 98 | 5,688 | 4,798 | 778 | 650 | 12,012 |
Impairment loss | — | — | (5) | — | — | (5) |
Currency translation differences | — | (379) | 83 | (100) | (183) | (579) |
Disposals | (96) | (1,018) | (86) | (62) | (459) | (1,721) |
At 31 December 2025 | 164 | 35,923 | 26,173 | 9,863 | 41,362 | 113,485 |
| Net book value | ||||||
At 1 January 2024 | 506 | 96,593 | 55,809 | 57,682 | 62,581 | 273,171 |
At 31 December 2024 | 268 | 22,971 | 5,306 | 7,915 | 28,430 | 64,890 |
At 31 December 2025 | 160 | 19,975 | 1,436 | 7,306 | 26,964 | 55,841 |
| £’000 | |
Proceeds from disposal | 102,814 |
Less: amount deducted at source | (2,149) |
Net proceeds from disposal | 100,665 |
Less: net assets disposed | (39,860) |
Less: disposal-related fees | (268) |
Gain on disposal | 60,537 |
| £’000 | |
Fair value of THG Ingenuity | 501,331 |
Less: carrying value of net assets and liabilities held for distribution | (172,697) |
Less: amounts relating to the finalisation of the demerger agreement in 2025 1 | (89,377) |
Less: intercompany receivable due from THG PLC 2 | (121,457) |
Gain on distribution | 117,800 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Goods held for resale | 205,251 | 200,533 |
Raw materials | 62,704 | 60,301 |
Goods in transit | 4,884 | 4,537 |
272,839 | 265,371 |
| 2025 | 2024 | ||
| Note | £’000 | £’000 | |
| Assets as per balance sheet – financial assets | |||
Trade and other receivables excluding non-financial assets | 15 | 70,403 | 70,770 |
Cash and cash equivalents | 16 | 183,099 | 308,622 |
| Assets as per balance sheet – held at fair value through OCI | |||
Derivative financial instruments designated as hedging instruments | 26,468 | 5,317 | |
279,970 | 384,709 | ||
| Liabilities as per balance sheet – other financial liabilities at amortised cost | |||
Bank borrowings | 18 | 430,360 | 604,567 |
Lease liabilities | 22 | 130,813 | 41,370 |
Trade and other payables excluding non-financial liabilities | 17 | 444,952 | 315,042 |
| Liabilities as per balance sheet – other financial liabilities at fair value | |||
Dividend liability | 12.2 | — | 501,331 |
Derivative financial instruments designated as hedging instruments | 63,793 | 58,969 | |
1,069,918 | 1,521,279 | ||
| Derivative financial instruments designated as hedging instruments | |||
FX forwards hedging foreign exchange risk on borrowings | (37,230) | (53,020) | |
Interest rate swaps | (843) | (1,303) | |
FX forwards hedging foreign exchange risk on highly probable future cash flows | 748 | 669 | |
(37,325) | (53,654) |
| Recycled | ||||
| through interest | ||||
| payable in the | ||||
| statement of | ||||
| Impact | Impact | comprehensive | ||
on OCI 1 | on OCI 2 | income | ||
2025 | Notional | £’000 | £’000 | £’000 |
| Notional | ||||
Derivatives hedging foreign exchange risk on borrowings | €445,000,000 | 5,839 | 7,784 | 13,075 |
Derivatives hedging interest rate risk on borrowings | €450,000,000 | (345) | (461) | 290 |
Derivatives hedging foreign exchange risk on future cash flows | £43,608,159 | (59) | (79) | (874) |
| Contractual amount | |||||||
| Carrying | Less than | 3 to 12 | 1 to 2 | 2 to 5 | More than | ||
| amount | Total | 3 months | months | years | years | 5 years | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
| 31 December 2025: | |||||||
Bank borrowings | 430,360 | 576,542 | 8,590 | 90,832 | 31,581 | 445,539 | — |
Lease liabilities | 130,813 | 192,572 | 5,267 | 15,678 | 20,978 | 60,051 | 90,598 |
Trade payables | 444,952 | 444,952 | 425,280 | 19,672 | — | — | — |
| Derivative financial | |||||||
liabilities | 63,793 | 63,793 | — | 63,793 | — | — | — |
| 31 December 2024: | |||||||
Bank borrowings | 604,567 | 610,339 | — | 112,785 | 497,554 | — | — |
Lease liabilities | 41,370 | 68,943 | 3,015 | 7,363 | 10,426 | 29,828 | 18,311 |
Trade payables | 315,042 | 315,042 | 286,041 | 29,001 | — | — | — |
| Derivative financial | |||||||
liabilities | 58,969 | 58,969 | — | 23,263 | 35,706 | — | — |
Dividend liability | 501,331 | 501,331 | 501,331 | — | — | — | — |
| Effect on | Effect on | Effect on | Effect on | ||
| Change | change in | change in | change in | change in | |
| in foreign | EUR rate 1 | USD rate 2 | PLN rate | JPY rate | |
| exchange rate | £’000 | £’000 | £’000 | £’000 | |
2025 | 5% | (811) | (5,247) | 56 | (8) |
2025 | -5% | 734 | 4,747 | (50) | 7 |
2024 | 5% | (215) | 2,235 | 140 | — |
2024 | -5% | 237 | (2,470) | 652 | — |
| New leases | Net repayment | Foreign | ||||||
| 1 January | Cash | and Lease | of bank | exchange | 31 December | |||
| 2025 | flows | modifications | borrowings | Disposals | movement | Other | 2025 | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Borrowings | 604,567 | (45,999) | — | (180,076) | — | 25,323 | 26,545 | 430,360 |
Lease liabilities | 41,370 | (20,645) | 105,474 | — | (379) | (1,450) | 6,443 | 130,813 |
Total liabilities from financing activities | 645,937 | (66,644) | 105,474 | (180,076) | (379) | 23,873 | 32,988 | 561,173 |
| New leases and | Net repayment | Foreign | ||||||
| 1 January | Cash | Lease | of bank | exchange | 31 December | |||
| 2024 | flows | modifications | borrowings | Disposals | movement | Other | 2024 | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Borrowings | 650,037 | (44,954) | — | (22,000) | — | (23,959) | 45,443 | 604,567 |
Lease liabilities | 344,977 | (47,476) | (1,914) | — | (213) | (1,942) | 15,867 | 309,299 1 |
Total liabilities from financing activities | 995,014 | (92,430) | (1,914) | (22,000) | (213) | (25,901) | 61,310 | 913,866 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Trade receivables | 38,252 | 34,578 |
Less: loss allowance | (222) | (1,122) |
Net trade receivables | 38,030 | 33,456 |
Prepayments | 16,063 | 13,253 |
Accrued income | 18,055 | 22,875 |
Other taxation and social security | 2,170 | 40,374 |
Other receivables | 32,373 | 37,314 |
106,691 | 147,272 |
| 2025 | 2024 | |
| £’000 | £,000 | |
Not due | 31,409 | 23,039 |
0 to 3 months overdue | 5,536 | 3,946 |
More than 3 months overdue | 1,307 | 7,593 |
38,252 | 34,578 |
| £’000 | |
At 1 January 2025 | 1,122 |
Charge for the year | 130 |
Released | (159) |
Utilised | (846) |
Foreign exchange movement | (25) |
At 31 December 2025 | 222 |
| 0-30 | 31-60 | 61-90 | 90+ | |||
| Current | days | days | days | days | Total | |
Expected credit loss rate | 0.49% | 0.52% | 0.54% | 0.57% | 0.64% | |
Estimated total gross carrying amount at default | 31,409 | 3,026 | (153) | 2,663 | 1,307 | 38,252 |
Expected credit loss | (178) | (18) | 1 | (17) | (10) | (222) |
At 31 December 2025 | 31,231 | 3,008 | (152) | 2,646 | 1,297 | 38,030 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Cash and cash equivalents | 183,099 | 308,622 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Trade payables | 333,911 | 246,035 |
Accruals | 111,041 | 69,007 |
Other taxation and social security | 19,880 | 27,485 |
464,832 | 342,527 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Carrying amount of trade payables that are part of the Group’s supplier financial arrangement | 32,368 | 44,762 |
Of which suppliers have received payment | 27,445 | 34,770 |
| 2025 | 2024 | ||
| Note | £’000 | £’000 | |
| Current | |||
Bank borrowings | 69,618 | 112,785 | |
Lease liabilities | 22 | 20,945 | 10,293 |
90,563 | 123,078 | ||
| Non-current | |||
Bank borrowings | 360,742 | 491,782 | |
Lease liabilities | 22 | 109,868 | 31,077 |
470,610 | 522,859 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Loans and other borrowings | (430,360) | (604,567) |
Lease liabilities | (130,813) | (41,370) |
Cash and cash equivalents | 183,099 | 308,622 |
Sub-total | (378,074) | (337,315) |
| Adjustments: | ||
Retranslate debt balance at swap rate where hedged by foreign exchange derivatives | 14,252 | (8,306) |
Net debt | (363,822) | (345,621) |
Net debt adjusted for demerger subleases | (363,822) | (422,521) |
Net debt before lease liabilities | (233,009) | (304,251) |
| Onerous | |||
| Dilapidations | contracts | Total | |
| £’000 | £’000 | £’000 | |
At 1 January 2025 | 12,077 | 6,303 | 18,380 |
Created | 7,964 | 504 | 8,468 |
Utilised | (3,112) | (4,276) | (7,388) |
Released | (637) | — | (637) |
Interest | 546 | — | 546 |
FX on retranslation | (106) | — | (106) |
At 31 December 2025 | 16,732 | 2,531 | 19,263 |
Current | 2,504 | 888 | 3,392 |
Non-current | 14,228 | 1,643 | 15,871 |
| Current | 1-5 years | 6-10 years | 11-15 years | 16-20 years | 21-25 years | Total | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
At 31 December 2025 | 4,803 | 2,038 | 1,998 | 245 | 9,068 | 1,270 | 19,422 |
At 31 December 2024 | 2,359 | 914 | 1,980 | — | 15,530 | — | 20,783 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Contract liabilities | 17,279 | 15,650 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Short-term timing differences | (10,170) | (4,725) |
Accelerated capital allowances | (6,851) | (478) |
Business combinations | 105,633 | 122,963 |
Tax losses | (32,758) | (46,366) |
Loan relationships | (11,786) | (15,993) |
Derivatives | (264) | 1,547 |
Other balance sheet amounts | — | 479 |
Total deferred tax liability | 43,804 | 57,427 |
| 2025 | 2024 | |
| £’000 | £’000 | |
| Continuing operations | ||
Deferred tax assets | (599) | (4,072) |
Deferred tax liabilities | 44,403 | 63,701 |
Net deferred tax liabilities | 43,804 | 59,629 |
| Discontinued operations | ||
Deferred tax assets | — | (2,705) |
Deferred tax liabilities | — | 503 |
Net deferred tax assets | — | (2,202) |
| Total | |
| £’000 | |
Opening balance 1 January 2025 | 59,629 |
Credited to the statement of comprehensive income | (8,643) |
Charged to equity | — |
Credited to OCI – exchange difference on translating foreign operations | (4,095) |
Credited to OCI – loss in cash flow hedges | (1,811) |
Movement arising from the acquisition or disposal of business | (1,276) |
Closing balance 31 December 2025 | 43,804 |
| 2025 | 2025 | 2024 | 2024 | |
| Gross amount | Tax affected | Gross amount | Tax affected | |
| £’000 | £’000 | £’000 | £’000 | |
| At 31 December: | ||||
Short-term timing difference (UK) | — | — | 14,538 | 3,635 |
Loan relationships (UK) | 201,349 | 50,337 | 120,572 | 30,143 |
Losses (UK) | 211,639 | 52,910 | 460,526 | 115,132 |
Fixed assets (UK) | — | — | 89,544 | 22,386 |
Losses (US) | — | — | 1,527 | 382 |
| Motor | Plant and | Land and | ||
| vehicles | machinery | buildings | Total | |
| £’000 | £’000 | £’000 | £’000 | |
As at 1 January 2024 | 1,656 | 113 | 301,866 | 303,635 |
Additions | — | — | 25,057 | 25,057 |
Depreciation (note 3) | (614) | (45) | (38,263) | (38,922) |
Lease modifications | (3) | — | (18,531) | (18,534) |
Disposals | — | — | (213) | (213) |
Transfers | — | — | (950) | (950) |
Currency translation differences | (4) | (1) | (1,147) | (1,152) |
Impairment | — | — | (7,372) | (7,372) |
Transfer to assets held for distribution | (807) | (35) | (231,380) | (232,222) |
As at 31 December 2024 | 228 | 32 | 29,067 | 29,327 |
Additions | — | — | 91,372 | 91,372 |
Depreciation (note 3) | (63) | — | (20,384) | (20,447) |
Lease modifications | — | (32) | 19,752 | 19,720 |
Disposals | — | — | (379) | (379) |
Currency translation differences | — | — | (1,956) | (1,956) |
Impairment (note 27) | — | — | (854) | (854) |
As at 31 December 2025 | 165 | — | 116,618 | 116,783 |
| 2025 | 2024 | |
| £’000 | £’000 | |
As at 1 January | 41,370 | 344,977 |
Additions | 83,440 | 15,950 |
Accretion of interest | 6,461 | 15,867 |
Payments | (20,645) | (47,476) |
Lease modifications | 22,034 | (17,864) |
Disposals | (397) | (213) |
Currency translation differences | (1,450) | (1,942) |
Transfer to liabilities held for distribution | — | (267,929) |
As at 31 December | 130,813 | 41,370 |
Current | 20,945 | 10,293 |
Non-current | 109,868 | 31,077 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Depreciation expense on right-of-use assets | 20,447 | 11,732 |
Interest expense on lease liabilities | 6,461 | 1,558 |
26,908 | 13,290 |
| Nominal | |||
| 2025 | 2024 | value | |
| Class | Number | Number | £ each |
Ordinary Shares | 1,599,781,137 | 1,322,058,529 | 0.005 |
B Shares | — | 204,081,632 | 0.005 |
D1 Shares | 56,082,651 | 56,082,651 | 0.005 |
D2 Shares | 17,066 | 17,066 | 1 |
E Shares | 48,571,808 | 48,605,750 | 0.005 |
F Shares | 26,685,406 | 26,715,453 | 0.005 |
G Shares | 16,841,351 | 16,885,866 | 0.005 |
Deferred 1 Shares | 204,404,691 | 323,059 | 0.005 |
Deferred 2 Shares | 21,563,860 | 21,563,860 | 0.005 |
1,973,947,970 | 1,696,333,866 |
| 2025 | 2024 | ||
| Note | £’000 | £’000 | |
Loss before taxation from continuing operations | (69,383) | (202,400) | |
Profit/(loss) before taxation from discontinued operations | 117,800 | (120,840) | |
Profit/(loss) before taxation | 48,417 | (323,240) | |
| Adjustments for: | |||
Depreciation of property, plant and equipment | 11 | 12,012 | 54,308 |
Depreciation of right-of-use assets | 22 | 20,447 | 38,922 |
Amortisation | 10 | 16,520 | 64,582 |
Amortisation of acquired intangibles | 10 | 41,886 | 47,917 |
Share-based payments | 7 | 7,903 | 16,579 |
Adjusted items | 4 | 30,227 | 146,400 |
Demerger gain | 12.2 | (117,800) | — |
Profit on disposal of subsidiary | 12.1 | (60,537) | — |
Net finance costs | 8 | 77,517 | 68,914 |
| Operating cash flow before adjusting items and before movements | |||
in working capital and provisions | 76,592 | 114,382 | |
Decrease in inventories | (14,543) | 1,280 | |
Decrease in trade and other receivables | 29,076 | 24,500 | |
Decrease in trade and other payables 1 | (28,664) | (9,798) | |
(Decrease)/increase in provisions | (7,662) | 6,084 | |
Foreign exchange gain/(loss) | 35 | (36) | |
Cash generated from operations before adjusting items | 54,834 | 136,412 |
2025 | 2024 | |
Loss for the financial year – continuing operations (£’000) | (63,675) | (180,533) |
Profit/(loss) for the financial year – discontinued operations (£’000) | 117,800 | (145,607) |
Total profit/(loss) for the financial year (£’000) | 54,125 | (326,140) |
Weighted average number of Ordinary Shares for basic and diluted EPS | 1,387,523,768 | 1,368,632,773 |
Basic and diluted EPS (£’s) | 0.04 | (0.24) |
Basic and Diluted EPS – continuing operations (£’s) | (0.04) | (0.13) |
Basic and diluted EPS – discontinued operations (£’s) | 0.08 | (0.11) |
| Ordinary | Ordinary | ||
| Shares | Shares | ||
| £ per | 2025 | 2024 | |
| share | Number | Number | |
M J Moulding | 0.005 | 358,233,396 | 269,702,708 |
M J Moulding | 1 | 360 | 360 |
J A Gallemore 1 | 0.005 | 4,216,826 | 4,216,826 |
J A Gallemore 1 | 1 | 3,174 | 3,174 |
D Sanders | 0.005 | 358,487 | 487,487 |
C Allen | 0.005 | 2,548,311 | 2,942,000 |
G Kent | 0.005 | 53,600 | 53,600 |
D Moore | 0.005 | 53,143 | 53,143 |
S Farr | 0.005 | 171,743 | 171,743 |
H Jones | 0.005 | 134,084 | 134,084 |
I McDonald 2 | 0.005 | n/a | 2,691,419 |
365,773,124 | 280,456,544 |
| 2025 | 2024 | ||||
| Subscription/ | Subscription/ | ||||
| exercise price | exercise price | 2025 | 2024 | ||
| Date of award | £ | £ | Number | Number | |
M J Moulding | Dec-19 | 0.23 | 0.23 | 43,641,266 | 43,641,266 |
M J Moulding | Aug-20 | 0.33 | 0.33 | 20,197,808 | 20,197,808 |
M J Moulding | Aug-20 | 0.28 | 0.28 | 7,733,792 | 7,733,792 |
J A Gallemore 1 | Dec-19 | 0.23 | 0.23 | 185,476 | 185,476 |
J A Gallemore 1 | Aug-20 | 0.33 | 0.33 | 2,666,963 | 2,666,963 |
J A Gallemore 1 | Aug-20 | 0.28 | 0.28 | 4,000,537 | 4,000,537 |
I McDonald 2 | Dec-19 | n/a | 0.23 | n/a | — |
78,425,842 | 78,425,842 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Right-of-use asset | 9,358 | 12,742 |
Lease liability | 25,025 | 24,025 |
Depreciation arising on right-of-use assets | 4,520 | 2,764 |
Expense recognised in financing costs | 1,233 | 991 |
Impairment arising on property, plant and equipment | 854 | 7,372 |
| Residual lease | ||
| term at | 2025 | |
| date of | rent | |
| Number of properties | divestment | £’000 |
6 | 0-4 years | 360 |
9 | 9-10 years | 1,998 |
1 | 18-24 years | 738 |
16 | 3,096 |
| Amount | Amounts | |
| owed by | owed to | |
| related | related | |
| parties | parties | |
| £’000 | £’000 | |
Aghoco 1422 Ltd | — | 800,000 |
Allenby Square Ltd | — | 2,400,000 |
THG Gadbrook PropCo Ltd | — | 549,012 |
— | 3,749,012 |
2025 | Proforma 2024 1 | |||
| Sale of | Purchase of | Sale of goods/ | Purchase of | |
| goods/services | goods/services | services | goods/services | |
| £’000 | £’000 | £’000 | £’000 | |
THG Ingenuity | 9,365 | 495,425 | 12,278 | 506,681 |
| 2025 | |
| £’000 | |
Right-of-use asset | 76,390 |
Lease liability | 76,901 |
Depreciation arising on right-of-use assets | 7,360 |
Expense recognised in financing costs | 4,951 |
| 2025 | ||
| Residual lease | rent | |
| Number of properties | term | £’000 |
3 | 0-4 years | 3,870 |
1 | 9-10 years | 723 |
3 | 18-24 years | 5,330 |
7 | 9,923 |
| Amount | Amounts | |
| owed by | owed to | |
| related parties | related parties | |
| £’000 | £’000 | |
FIC Shareco Limited | 674 | 67,306 |
The Hut.com Poland | — | 311 |
THG International LLC | — | 1,000 |
674 | 68,617 |
| Registered | Country of | Nature of | |
| Subsidiary | office | incorporation | business |
The Hut Holdings Limited | 1 | England and Wales | Dormant |
Cend Limited | 1 | England and Wales | Holding company |
Ensco 818 Limited | 1 | England and Wales | Holding company |
Mankind Holdings Limited | 2 | Guernsey | Holding company |
Mankind Direct Limited | 1 | England and Wales | Dormant |
Lookfantastic Group Limited | 1 | England and Wales | Holding company |
Lookfantastic.com Ltd | 1 | England and Wales | Holding company |
Lookfantastic Franchising Limited | 1 | England and Wales | Holding company |
Lookfantastic Salons Limited | 1 | England and Wales | Holding company |
Exante Diet Limited | 1 | England and Wales | Dormant |
Bike Kit Limited | 1 | England and Wales | Dormant |
CNP Professional Holdings Limited | 2 | Guernsey | Holding company |
MyVitamins Limited | 1 | England and Wales | Dormant |
HQ Hair Limited | 2 | Guernsey | Holding company |
Cend International Limited | 1 | England and Wales | Holding company |
Mama Mio Limited | 1 | England and Wales | Holding company |
Mama Mio Distribution Limited | 1 | England and Wales | Dormant |
Mama Mio US, LLC | 5 | USA | Holding company |
Gadbrook Limited | 1 | England and Wales | Holding company |
THG International Limited | 1 | England and Wales | Marketing company |
The Hut Group International (Shanghai) Co Limited | 7 | China | Licence holding company |
PC Beauty Inc. | 1 | USA | Holding company |
| Registered | Country of | Nature of | ||
| Subsidiary | office | incorporation | business | |
Performance Supplements LLC | 5 | USA | Holding company | |
Salu Australia PTY Limited | 11 | Australia | Holding company | |
Skincarestore Australia PTY Limited | 11 | Australia | Online retailing | |
Salu Beauty, LLC | 1 | USA | Holding company | |
THG Beauty Aus Pty Ltd (previously RY.com.au Pty Limited) | 11 | Australia | Online retailing | |
Media Ark Limited | 1 | England and Wales | Holding company | |
Illamasqua (Holdings) Limited | 1 | England and Wales | Holding company | |
Illamasqua Limited | 1 | England and Wales | Holding company | |
Beauty Box Beteiligungen GmbH | 12 | Germany | Holding company | |
Beauty Trend Holding GmbH | 12 | Germany | Online retailing | |
Beauty Trend GmbH | 12 | Germany | Online retailing | |
Jade 1150. GmbH | 12 | Germany | Holding company | |
Beauty Trend S.A.S France | 3 | France | Holding company | |
GlossyBox Sweden Holding UG | 12 | Germany | Holding company | |
GlossyBox Sweden AB | 17 | Sweden | Online retailing | |
GlossyBox United Kingdom Holding GmbH | 12 | Germany | Holding company | |
Beauty Trend UK Limited | 1 | England and Wales | Online retailing | |
VRB GmbH & Co. B-149 KG | 12 | Germany | Holding company | |
Beauty Trend USA Inc. | 5 | USA | Online retailing | |
EI Spa Holdings (UK) Limited | 1 | England and Wales | Holding company | |
ESPA International (UK) Limited | 1 | England and Wales | Holding company | |
Primavera Aromatherapy Limited | 1 | England and Wales | Holding company | |
ESPA International (US) LLC | 5 | USA | Holding company | |
ESPA International FZE | 8 | UAE | Holding company | |
Make Money Limited | 1 | England and Wales | Holding company | |
M Beauty Limited | 1 | England and Wales | Holding company | |
Acheson & Acheson Limited | 1 | England and Wales | Manufacturing | |
1010 | Products Limited | 1 | England and Wales | Dormant |
Ameliorate Skincare Limited | 1 | England and Wales | Holding company | |
Great John Street Hotel Limited | 1 | England and Wales | Hotel operator | |
THG Trustee Limited 1 | 1 | England and Wales | Trustee of EBT | |
THG Nutrition US Inc. | 1 | USA | Holding company | |
Myprotein Japan K.K. | 6 | Japan | Online retailing | |
Colorist Christophe Robin S.A.S. | 18 | France | Online retailing | |
Colorist Christophe Robin US LLC | 5 | USA | Holding company | |
THG General Trading LLC | 15 | UAE | Online retailing | |
David Berryman Ltd | 1 | England and Wales | Online retailing | |
David Berryman Holdings Limited | 1 | England and Wales | Holding company | |
Fair Juice Limited | 1 | England and Wales | Dormant | |
THG 100 | KING STREET LIMITED | 1 | England and Wales | Holding company |
Lion/Wrinkle Holdings, LLC | 1 | USA | Holding company | |
Lion/Wrinkle Parent LLC | 1 | USA | Holding company | |
Lion/Wrinkle Intermediate LLC | 1 | USA | Holding company | |
N.V. Perricone LLC | 5 | USA | Holding company | |
Perricone MD Cosmeceuticals UK Limited | 1 | England and Wales | Holding company | |
THG Intermediate OpCo Limited | 1 | England and Wales | Holding company | |
THG Operations Holdings Limited | 1 | England and Wales | Holding company | |
THG Intermediate Holdings Limited 1 | 1 | England and Wales | Holding company | |
THG Shelfco Limited | 1 | England and Wales | Holding company | |
THG Beauty USA LLC | 5 | USA | Online retailing | |
The Protein Lab (UK) Limited | 1 | England and Wales | Manufacturing | |
Brighter Foods Limited | 1 | England and Wales | Manufacturing | |
Bentley Laboratories Blocker Company | 5 | USA | Holding company | |
Bentley Laboratories LLC | 10 | USA | Manufacturing | |
Cult Beauty Limited | 1 | England and Wales | Holding company | |
THG Beauty Limited | 1 | England and Wales | Online retailing | |
| Registered | Country of | Nature of | |
| Subsidiary | office | incorporation | business |
THG Beauty Singapore PTE Limited | 13 | Singapore | Online retailing |
THG Luxury Limited | 1 | England and Wales | Online retailing |
THG Nutrition Limited | 1 | England and Wales | Online retailing |
THG AUS Nutrition PTY Limited | 11 | Australia | Online retailing |
THG Nutrition India Private Limited | 14 | India | Online retailing |
THG Nutrition Singapore PTE Limited | 13 | Singapore | Online retailing |
THG Nutrition Poland s.p.z.o.o | 4 | Poland | Online retailing |
THG Beauty Europe GmbH | 12 | USA | Online retailing |
THG Shared Services Limited | 1 | England and Wales | Shared Service centre |
THG Shared Services AUS PTY Limited | 11 | Australia | Shared Service centre |
THG Shared Services Poland sp.z.o.o | 4 | Poland | Shared Service centre |
THG Shared Services US LLC | 9 | USA | Shared Service centre |
THG Beauty Trading LLC | 16 | UAE | Online retailing |
THG Insurance Limited 1 | 2 | Guernsey | Holding company |
Dermstore LLC | 1 | USA | Holding company |
THG Beauty I2 Limited | 1 | England and Wales | Online retailing |
THG Nutrition OM Limited | 1 | England and Wales | Online retailing |
Name | Company number | |
Ensco 818 Limited | 7459909 | |
Lookfantastic Group Limited | 5381562 | |
Illamasqua (Holdings) Limited | 6116121 | |
EI Spa Holdings (UK) Limited | 9317257 | |
Make Money Limited | 5880897 | |
THG Intermediate Holdings Limited | 12526036 | |
Lookfantastic.com Ltd | 3519634 | |
Mankind Direct Limited | 4112104 | |
Cend Limited | 4067712 | |
THG Shared Services Limited | 13515579 | |
The Protein Lab (UK) Limited | 8491800 | |
THG Nutrition Limited | 13400484 | |
Gadbrook Limited | 9867117 | |
Lookfantastic London Limited | 6338404 | |
Mama Mio Distribution Limited | 7721655 | |
Fair Juice Limited | 6494686 | |
Beauty Trend UK Limited | 7569585 | |
THG International Limited | 10523712 | |
Illamasqua Limited | 6301971 | |
Primavera Aromatherapy Limited | 2053064 | |
M Beauty Limited | 5850964 | |
THG 100 | KING STREET LIMITED | 12938227 |
Cend International Limited | 8651475 | |
ESPA International (UK) Limited | 2742156 | |
Acheson & Acheson Limited | 2764368 | |
Great John Street Hotel Limited | 7973960 | |
THG Beauty Limited | 13400467 | |
THG Luxury Limited | 13515580 | |
Media Ark Limited | 6127322 | |
Ameliorate Skincare Limited | 3427037 | |
THG Trustee Limited | 10511000 | |
THG Intermediate OpCo Limited | 12297092 | |
David Berryman Holdings Limited | 10392135 | |
David Berryman Ltd | 2185279 | |
Perricone MD Cosmeceuticals UK Limited | 6471993 | |
Lookfantastic Franchising Limited | 5382066 | |
Lookfantastic Salons Limited | 6310534 | |
Mama Mio Limited | 5251791 | |
Brighter Foods Limited | 8815259 | |
Cult Beauty Limited | 6195011 | |
Bike Kit Limited | 8317188 | |
The Hut Holdings Limited | 7002848 | |
Exante Diet Limited | 7126424 | |
1010 | Products Limited | 3402920 |
Myvitamins Limited | 8179216 | |
THG Shelfco Limited | 13120197 | |
THG Beauty I2 Limited | 16379955 | |
THG Nutrition OM Limited | 16379964 | |